Paper23224977
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.
Abou DS and 7 others. Pharm Res, 2013. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer. Papers, record 23224977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23224977
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contrast Media | Major topic |
| Gadolinium | Major topic |
| Liposomes | Major topic |
| Neuroendocrine Tumors | Major topic |
| Octreotide | Major topic |
| Zirconium | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Humans | |
| Isotopes | |
| Magnetic Resonance Imaging | |
| Mice | |
| Positron-Emission Tomography | |
| Receptors, Somatostatin |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| P50 CA086438 | NCI NIH HHS | United States | P50CA086438 | PubMed and NIH | NIH RePORTER |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10699287 | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. | J Control Release | 2000 | https://conductscience.org/library/papers/10699287 | PubMed |
| 2 | 1390763 | Peptide binding to lipid bilayers. Nonclassical hydrophobic effect and membrane-induced pK shifts. | Biochemistry | 1992 | https://conductscience.org/library/papers/1390763 | PubMed |
| 3 | 16155762 | Relaxivity of liposomal paramagnetic MRI contrast agents. | MAGMA | 2005 | https://conductscience.org/library/papers/16155762 | PubMed |
| 4 | 6892980 | Colorimetric determination of phospholipids with ammonium ferrothiocyanate. | Anal Biochem | 1980 | https://conductscience.org/library/papers/6892980 | PubMed |
| 5 | 20660376 | 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. | J Nucl Med | 2010 | https://conductscience.org/library/papers/20660376 | PubMed |
| 6 | 20049780 | Radioactive liposomes. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2009 | https://conductscience.org/library/papers/20049780 | PubMed |
| 7 | 10398986 | MR imaging in patients with intraspinal bullets. | J Magn Reson Imaging | 1999 | https://conductscience.org/library/papers/10398986 | PubMed |
| 8 | 15198567 | Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery. | AAPS PharmSciTech | 2003 | https://conductscience.org/library/papers/15198567 | PubMed |
| 9 | 21718943 | In vivo biodistribution and accumulation of 89Zr in mice. | Nucl Med Biol | 2011 | https://conductscience.org/library/papers/21718943 | PubMed |
| 10 | 22017398 | Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts. | Cancer Sci | 2012 | https://conductscience.org/library/papers/22017398 | PubMed |
| 11 | 19720285 | Standardized methods for the production of high specific-activity zirconium-89. | Nucl Med Biol | 2009 | https://conductscience.org/library/papers/19720285 | PubMed |
| 12 | 18972531 | Paramagnetic liposomes as innovative contrast agents for magnetic resonance (MR) molecular imaging applications. | Chem Biodivers | 2008 | https://conductscience.org/library/papers/18972531 | PubMed |
| 13 | 21030757 | Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo. | Nanotechnology | 2010 | https://conductscience.org/library/papers/21030757 | PubMed |
| 14 | 17504879 | Partial-volume effect in PET tumor imaging. | J Nucl Med | 2007 | https://conductscience.org/library/papers/17504879 | PubMed |
| 15 | 18319342 | Simultaneous in vivo positron emission tomography and magnetic resonance imaging. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18319342 | PubMed |
| 16 | 17445505 | Multimodality registration without a dedicated multimodality scanner. | Mol Imaging | 2007 | https://conductscience.org/library/papers/17445505 | PubMed |
| 17 | 9671697 | A model for MRI contrast enhancement using T1 agents. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9671697 | PubMed |
| 18 | 34148 | Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/34148 | PubMed |
| 19 | 21166471 | Octreotide-targeted liposomes loaded with CPT-11 enhanced cytotoxicity for the treatment of medullary thyroid carcinoma. | Mol Pharm | 2011 | https://conductscience.org/library/papers/21166471 | PubMed |
| 20 | 19276264 | Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19276264 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42518685 | Nanomedicine-Based Strategies for Multiple Myeloma Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42518685 | PubMed |
| 41012496 | Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology). | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012496 | PubMed |
| 39407431 | Nanoscale Radiotheranostics for Cancer Treatment: From Bench to Bedside. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2024 | https://conductscience.org/library/papers/39407431 | PubMed |
| 36865684 | Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts. | Cancer Nanotechnol | 2023 | https://conductscience.org/library/papers/36865684 | PubMed |
| 36811810 | Nanoparticles labeled with gamma-emitting radioisotopes: an attractive approach for in vivo tracking using SPECT imaging. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/36811810 | PubMed |
| 35665368 | Pathogenesis and treatment of multiple myeloma. | MedComm (2020) | 2022 | https://conductscience.org/library/papers/35665368 | PubMed |
| 35224973 | PET Imaging of Small Extracellular Vesicles via [89Zr]Zr(oxinate)4 Direct Radiolabeling. | Bioconjug Chem | 2022 | https://conductscience.org/library/papers/35224973 | PubMed |
| 35002239 | Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/35002239 | PubMed |
| 34578765 | Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/34578765 | PubMed |
| 34575511 | Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34575511 | PubMed |
| 33277399 | Metallofluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI. | J Nucl Med | 2021 | https://conductscience.org/library/papers/33277399 | PubMed |
| 32607918 | Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution. | EJNMMI Res | 2020 | https://conductscience.org/library/papers/32607918 | PubMed |
| 32314552 | Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2020 | https://conductscience.org/library/papers/32314552 | PubMed |
| 32226525 | PET Imaging of Liposomal Glucocorticoids using 89Zr-oxine: Theranostic Applications in Inflammatory Arthritis. | Theranostics | 2020 | https://conductscience.org/library/papers/32226525 | PubMed |
| 32223222 | Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma. | ACS Nano | 2020 | https://conductscience.org/library/papers/32223222 | PubMed |
| 32171101 | Radio-metal cross-linking of alginate hydrogels for non-invasive in vivo imaging. | Biomaterials | 2020 | https://conductscience.org/library/papers/32171101 | PubMed |
| 31905769 | Radiolabeled PET/MRI Nanoparticles for Tumor Imaging. | J Clin Med | 2019 | https://conductscience.org/library/papers/31905769 | PubMed |
| 31315207 | In Vivo Tracking of Tissue Engineered Constructs. | Micromachines (Basel) | 2019 | https://conductscience.org/library/papers/31315207 | PubMed |
| 31170428 | Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine. | Adv Drug Deliv Rev | 2019 | https://conductscience.org/library/papers/31170428 | PubMed |
| 30613293 | PET-MR and SPECT-MR multimodality probes: Development and challenges. | Theranostics | 2018 | https://conductscience.org/library/papers/30613293 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SSTR2 | 6752 | PubTator's text mining | https://conductscience.org/library/genes/6752 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23224977
GET https://conductscience.org/api/papers/v1/23224977/references?page=2